The phosphatase calcineurin regulates pathological TDP-43 phosphorylation

[1]  E. Buratti,et al.  TDP-43 affects splicing profiles and isoform production of genes involved in the apoptotic and mitotic cellular pathways , 2015, Nucleic acids research.

[2]  K. Wada,et al.  4-Hydroxynonenal induces persistent insolubilization of TDP-43 and alters its intracellular localization. , 2015, Biochemical and biophysical research communications.

[3]  Hong-Yu Hu,et al.  TDP‐35 sequesters TDP‐43 into cytoplasmic inclusions through binding with RNA , 2015, FEBS letters.

[4]  B. Miller,et al.  Frontotemporal dementia: a bridge between dementia and neuromuscular disease , 2015, Annals of the New York Academy of Sciences.

[5]  J. Trojanowski,et al.  An acetylation switch controls TDP-43 function and aggregation propensity , 2015, Nature Communications.

[6]  M. Pellegrini,et al.  Identification of RNA polymerase III-transcribed Alu loci by computational screening of RNA-Seq data , 2014, Nucleic acids research.

[7]  Thomas J. Montine,et al.  The Tau Tubulin Kinases TTBK1/2 Promote Accumulation of Pathological TDP-43 , 2014, PLoS genetics.

[8]  Yun‐Min Zheng,et al.  Calcineurin upregulates local Ca(2+) signaling through ryanodine receptor-1 in airway smooth muscle cells. , 2014, American journal of physiology. Lung cellular and molecular physiology.

[9]  A. Lees,et al.  TDP‐43 pathology is present in most post‐encephalitic parkinsonism brains , 2014, Neuropathology and applied neurobiology.

[10]  C. Jack,et al.  TDP-43 is a key player in the clinical features associated with Alzheimer’s disease , 2014, Acta Neuropathologica.

[11]  D. Bennett,et al.  TDP-43 pathology, cognitive decline, and dementia in old age. , 2013, JAMA neurology.

[12]  T. Bird,et al.  CDC7 inhibition blocks pathological TDP‐43 phosphorylation and neurodegeneration , 2013, Annals of neurology.

[13]  K. Baumgärtel,et al.  Neural functions of calcineurin in synaptic plasticity and memory. , 2012, Learning & memory.

[14]  A. Kakita,et al.  Alteration of POLDIP3 Splicing Associated with Loss of Function of TDP-43 in Tissues Affected with ALS , 2012, PloS one.

[15]  G. Sobue,et al.  Oxidative stress induced by glutathione depletion reproduces pathological modifications of TDP-43 linked to TDP-43 proteinopathies , 2012, Neurobiology of Disease.

[16]  J. Schneider,et al.  National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease , 2012, Alzheimer's & Dementia.

[17]  A. Zell,et al.  TDP-43 regulates global translational yield by splicing of exon junction complex component SKAR , 2011, Nucleic acids research.

[18]  J. Trojanowski,et al.  A harmonized classification system for FTLD-TDP pathology , 2011, Acta Neuropathologica.

[19]  Hong-Yu Hu,et al.  Aggregation of the 35‐kDa fragment of TDP‐43 causes formation of cytoplasmic inclusions and alteration of RNA processing , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[20]  O. Brady,et al.  Regulation of TDP‐43 aggregation by phosphorylation andp62/SQSTM1 , 2011, Journal of neurochemistry.

[21]  Nicole F. Liachko,et al.  Phosphorylation Promotes Neurotoxicity in a Caenorhabditis elegans Model of TDP-43 Proteinopathy , 2010, The Journal of Neuroscience.

[22]  L. Petrucelli,et al.  Phosphorylation regulates proteasomal-mediated degradation and solubility of TAR DNA binding protein-43 C-terminal fragments , 2010, Molecular Neurodegeneration.

[23]  R. Tibbetts,et al.  Amyotrophic Lateral Sclerosis-associated Proteins TDP-43 and FUS/TLS Function in a Common Biochemical Complex to Co-regulate HDAC6 mRNA* , 2010, The Journal of Biological Chemistry.

[24]  C. Marescaux,et al.  Tacrolimus-Associated Posterior Reversible Encephalopathy Syndrome after Solid Organ Transplantation , 2010, European Neurology.

[25]  E. Bigio,et al.  Phosphorylated TDP-43 pathology and hippocampal sclerosis in progressive supranuclear palsy , 2010, Acta Neuropathologica.

[26]  A. Levey,et al.  Multiplex SILAC Analysis of a Cellular TDP-43 Proteinopathy Model Reveals Protein Inclusions Associated with SUMOylation and Diverse Polyubiquitin Chains* , 2010, Molecular & Cellular Proteomics.

[27]  G. Schellenberg,et al.  SUT-2 potentiates tau-induced neurotoxicity in Caenorhabditis elegans. , 2009, Human molecular genetics.

[28]  Y. Hirayasu,et al.  Accumulation of phosphorylated TDP-43 in brains of patients with argyrophilic grain disease , 2009, Acta Neuropathologica.

[29]  J. Trojanowski,et al.  Phosphorylation of S409/410 of TDP-43 is a consistent feature in all sporadic and familial forms of TDP-43 proteinopathies , 2009, Acta Neuropathologica.

[30]  P. Mcgeer,et al.  Colocalization of Transactivation-Responsive DNA-Binding Protein 43 and Huntingtin in Inclusions of Huntington Disease , 2008, Journal of neuropathology and experimental neurology.

[31]  Andrea D'Ambrogio,et al.  Structural determinants of the cellular localization and shuttling of TDP-43 , 2008, Journal of Cell Science.

[32]  J. Trojanowski,et al.  Two German kindreds with familial amyotrophic lateral sclerosis due to TARDBP mutations. , 2008, Archives of neurology.

[33]  D. Geschwind,et al.  Novel Mutations in TARDBP (TDP-43) in Patients with Familial Amyotrophic Lateral Sclerosis , 2008, PLoS genetics.

[34]  T. Beach,et al.  Abnormal phosphorylation of Ser409/410 of TDP‐43 in FTLD‐U and ALS , 2008, FEBS letters.

[35]  M. Morita,et al.  Phosphorylated TDP‐43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis , 2008, Annals of neurology.

[36]  Paulo Fontes,et al.  Age, model for end‐stage liver disease score, and organ functioning predict posttransplant tacrolimus neurotoxicity , 2008, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[37]  J. Trojanowski,et al.  Concomitant TAR-DNA-Binding Protein 43 Pathology Is Present in Alzheimer Disease and Corticobasal Degeneration but Not in Other Tauopathies , 2008, Journal of neuropathology and experimental neurology.

[38]  C. Jack,et al.  Abnormal TDP-43 immunoreactivity in AD modifies clinicopathologic and radiologic phenotype , 2008, Neurology.

[39]  B. McConkey,et al.  TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis , 2008, Nature Genetics.

[40]  Murray Grossman,et al.  TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: a genetic and histopathological analysis , 2008, The Lancet Neurology.

[41]  Xun Hu,et al.  TDP-43 Mutations in Familial and Sporadic Amyotrophic Lateral Sclerosis , 2008, Science.

[42]  H. Arai,et al.  Concurrence of TDP-43, tau and α-synuclein pathology in brains of Alzheimer's disease and dementia with Lewy bodies , 2007, Brain Research.

[43]  John L. Robinson,et al.  Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases , 2007, Acta Neuropathologica.

[44]  D. Dickson,et al.  TDP‐43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease , 2007, Annals of neurology.

[45]  H. Akiyama,et al.  TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. , 2006, Biochemical and biophysical research communications.

[46]  Bruce L. Miller,et al.  Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis , 2006, Science.

[47]  Satohiro Masuda,et al.  An up-date review on individualized dosage adjustment of calcineurin inhibitors in organ transplant patients. , 2006, Pharmacology & therapeutics.

[48]  S. Bolsover.  Calcium signalling in growth cone migration. , 2005, Cell calcium.

[49]  A. Chiò,et al.  Activity of protein phosphatase calcineurin is decreased in sporadic and familial amyotrophic lateral sclerosispatients , 2004, Journal of neurochemistry.

[50]  D. H. Kim,et al.  Calcineurin, a calcium/calmodulin-dependent protein phosphatase, is involved in movement, fertility, egg laying, and growth in Caenorhabditis elegans. , 2002, Molecular biology of the cell.

[51]  I. Mori,et al.  Negative Regulation and Gain Control of Sensory Neurons by the C. elegans Calcineurin TAX-6 , 2002, Neuron.

[52]  J. Hamada,et al.  Potential role of calcineurin for brain ischemia and traumatic injury , 1999, Progress in Neurobiology.

[53]  E. Jorgensen,et al.  Identification and characterization of the vesicular GABA transporter , 1997, Nature.

[54]  R. Kincaid,et al.  Molecular cloning and chromosomal mapping of the human gene for the testis-specific catalytic subunit of calmodulin-dependent protein phosphatase (calcineurin A). , 1992, Biochemical and biophysical research communications.

[55]  J. Polli,et al.  Expression of the calmodulin-dependent protein phosphatase, calcineurin, in rat brain: developmental patterns and the role of nigrostriatal innervation. , 1991, Brain research. Developmental brain research.

[56]  Stuart L. Schreiber,et al.  Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes , 1991, Cell.

[57]  J. H. Wang,et al.  Regulation of calcineurin by metal ions. Mechanism of activation by Ni2+ and an enhanced response to Ca2+/calmodulin. , 1984, The Journal of biological chemistry.

[58]  M. King,et al.  Activation of calcineurin by nickel ions. , 1983, Biochemical and biophysical research communications.

[59]  C. Klee,et al.  Calcineurin: a calcium- and calmodulin-binding protein of the nervous system. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[60]  D. Grzybicki,et al.  TDP-43 Proteinopathy and Motor Neuron Disease in Chronic Traumatic Encephalopathy , 2012 .

[61]  Charles Duyckaerts,et al.  National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach , 2011, Acta Neuropathologica.

[62]  F. Shibasaki,et al.  Calcineurin as a multifunctional regulator. , 2002, Journal of biochemistry.